CompanyDeals

JW Therapeutics Secures Supply Agreement with Juno to Advance CAR-T Therapy Commercialization

CompanyDrug

HighTide Therapeutics’ HTD1801 Meets Primary and Secondary Endpoints in Type 2 Diabetes Phase II Study

CompanyDeals

GenScript Biotech’s Legend Biotech Secures Private Placement with Hillhouse Investment

CompanyDrug

Zhejiang Conba Pharmaceutical’s Inhalable Pirfenidone for IPF Clears for Chinese Clinical Trials

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for Two Autoimmune Disease Drug Candidates

CompanyDrug

Sino-US Laekna Receives FDA Clearance for LAE102 Clinical Trial in NSCLC

Policy / Regulatory

Beijing Hospitals to Pilot DRG-VBP Reforms for Medical Consumables Procurement

Company

Lundbeck A/S Reports Record Quarterly Revenue in Q1 2023 with 11% YOY Increase

CompanyDrug

Cabaletta Bio’s CABA-201 Clears FDA for Phase I/II Study in Idiopathic Inflammatory Myopathy

CompanyDeals

MicroPort Scientific Plans IPO for Subsidiary MicroPort CRM on Hong Kong Stock Exchange

CompanyDeals

Mustang Bio, Inc. Enters Strategic Partnership with uBriGene for Cell and Gene Therapy

CompanyDeals

Beijing Sun-Novo Secures Exclusive Rights to Kaneka’s Skin Patch Drugs in Licensing Deal